Article Text

Download PDFPDF
Lemierre’s syndrome involving milleri group streptococci: further insight into age and aetiology
  1. Christian A Linares1,
  2. Felicity Ryan1,
  3. Imran Hajat2 and
  4. Stephen Glass1
  1. 1Medical Microbiology Service, East Kent Hospitals University NHS Foundation Trust, Ashford, Kent, UK
  2. 2Otolaryngology Department, East Kent Hospitals University NHS Foundation Trust, Ashford, Kent, UK
  1. Correspondence to Dr Christian A Linares; christian.linares{at}nhs.net

Abstract

Lemierre’s syndrome (LS) is a suppurative thrombophlebitis of the internal jugular vein secondary to otorhinolaryngologic infection. It is classically associated with the Gram-negative anaerobe Fusobacterium necrophorum (FN) and is thought to be a disease of young people. Here, we describe the case of a 56-year-old woman with LS involving milleri group streptococci (MGS), which has been reported only 13 times since it was first observed in 2003. Subgroup analysis of all published cases of LS involving MGS demonstrated these patients were significantly older than those involving FN (median age 49 years versus 18 years, p = 0.007, IQR 36–58 years), although this finding is limited by publication bias. This report clarifies a 2014 hypothesis regarding the relationship between age and aetiology in this rare disease. While FN remains the most common cause of LS overall, empiric antibiotic therapy should also cover oral streptococci such as MGS, even in younger adults.

  • infectious diseases
  • otolaryngology / ENT

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors CAL managed and analysed the data and wrote the manuscript. FR performed the microbiological laboratory tests. IH was responsible for the clinical care of this patient. CAL, FR, IH and SG edited and approved the final manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.